ArticleFoods (Basel, Switzerland)2026
Sulforaphane Microcapsules via O/W Emulsion: Development, Characterization, and Application in Functional Yogurt.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sulforaphane (SFN) is an anti-cancer isothiocyanate occurring in Brassicaceae. SFN is decomposed by heat, oxygen, and alkaline conditions. Microencapsulation is a way to improve its stability. This work presents the development of SFN microcapsules using an oil-in-water emulsion with gum arabic (GA) as the wall material for incorporation into yogurt. The process for obtaining SFN microcapsules was optimized using response surface methodology. The optimal microencapsulation conditions were 7 min of stirring, an SFN/GA mass ratio of 0.7, and a surfactant concentration of 7%, resulting in an entrapment efficiency of 90.0 ± 3.0%, the highest reported. The microcapsules had a regular spherical shape with 0.5-5.5 µm diameter and no cracks. Freezing temperature (-4 °C) preserved 100% of SFN in the microcapsule for 90 days. Yogurt added with SFN microcapsules maintained physical and microbiological quality. SFN retention in yogurt after 30 days was 57% when microencapsulated, showing a 14-fold reduction in the kinetic degradation constant compared with free SFN, confirming the efficacy of this method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.